#Health Innovation

A groundbreaking blood test has been developed to aid in the diagnosis and management of Alzheimer’s disease, providing hope for those experiencing cognitive decline. This innovation enables doctors to determine the presence and progression of Alzheimer’s, offering a significant leap forward in personalizing patient care. The test can potentially identify suitable drug therapies earlier in the disease’s progression, making treatments like donanemab and lecanemab more effective, as these are beneficial primarily in early-stage Alzheimer’s.